Search clinical trials for: metastatic ER /HER2- breast cancer
Total 399475 results
-
AstraZenecaRecruitingHER2-negativeDominican Republic, Panama, India, Brazil, Thailand, Indonesia, Malaysia, Mexico, Philippines, Singapore, Vietnam
-
Novartis PharmaceuticalsCompletedFirst or Second Line HER2-negative Breast Cancer | Metastatic Disease Without Bone MetastasisUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
-
National Cancer Institute (NCI)WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, China, Hungary, Singapore, Australia, Russian Federation, Hong Kong, Brazil, Croatia, Korea, Republic of
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
Dantari, Inc.CompletedHER2-negative Metastatic Breast CancerUnited States
-
Novartis PharmaceuticalsAvailableHR+, HER2-, Advanced Breast Cancer
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHER2 Positive Metastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Black Diamond Therapeutics, Inc.TerminatedSolid TumorUnited States, Denmark, France, Spain
-
Novartis PharmaceuticalsCompletedBreast CancerChina, United States, France, Italy, United Kingdom, Taiwan, Turkey, Egypt, Germany, Hong Kong, Belgium, Canada, Russian Federation, Lebanon, Japan, Australia, Greece, Korea, Republic of, Ireland, Peru, Argentina, Brazil, Colombia, South... and more
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedMetastatic Breast Cancer | Recurrent Breast CancerChina
-
MedSIRNovartisActive, not recruiting
-
Carisma Therapeutics IncActive, not recruitingAdenocarcinoma | Stomach Neoplasms | Cancer | Breast Cancer | Head and Neck Cancer | Carcinoma, Hepatocellular | Colorectal Cancer | Pancreatic Cancer | Ovarian Neoplasms | Carcinoma, Ovarian Epithelial | Carcinoma, Transitional Cell | Breast Neoplasm | Prostate Cancer | Bile Duct Cancer | Bladder Cancer | Endometrial Cancer and other conditionsUnited States
-
MedSIREli Lilly and CompanyActive, not recruitingBreast Cancer MetastaticItaly, Spain, Portugal
-
Seoul National University HospitalSeoul National University Bundang Hospital; Korean Cancer Study Group (KCSG); Eisai Korea Inc... and other collaboratorsActive, not recruitingMetastatic Breast CancerKorea, Republic of
-
Zhejiang Cancer HospitalProswell Medical CorporationRecruitingMetastatic Breast CancerChina
-
Mahdis BayatCompletedHER2 Low Breast Carcinoma
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerGermany
-
AstraZenecaCompleted
-
The First Affiliated Hospital with Nanjing Medical...First Affiliated Hospital of Wenzhou Medical UniversityRecruiting
-
Korean South West Oncology GroupWithdrawnGastric CancerKorea, Republic of
-
Eisai Co., Ltd.CompletedBreast Cancer | Breast Tumors | Triple Negative Breast Cancer | Cancer of Breast | HER2-Negative Breast CancerChina
-
Accutar Biotechnology IncTerminatedBreast CancerUnited States
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Breast CancerKorea, Republic of, Taiwan, Hong Kong, United States, Japan, Croatia, United Kingdom, Hungary, Australia, Canada, Serbia, Singapore, South Africa, Poland, Spain, Russian Federation, Romania, Austria, Belgium, Bulgaria, Czechia, Fr... and more
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Finland, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Gua... and more
-
Institut fuer FrauengesundheitSamsung Bioepis Co., Ltd.RecruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer FemaleGermany
-
University of Texas Southwestern Medical CenterGateway for Cancer Research; Celldex TherapeuticsRecruitingMetastatic Breast Cancer | HER2-negative Breast CancerUnited States
-
Saint Luke's Health SystemNovartis PharmaceuticalsRecruitingMetastatic Breast Cancer | HER2-negative Breast CancerUnited States
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave... and other collaboratorsRecruitingHER2-negative Breast Cancer | ER+ Breast CancerUnited Kingdom, France
-
Sun Yat-sen UniversityRecruitingBreast Cancer | Breast Diseases | HER2-positive Breast Cancer | Vinorelbine | PyrotinibChina
-
Ahon Pharmaceutical Co., Ltd.Zhejiang Cancer Hospital; Fudan University; Sir Run Run Shaw HospitalUnknown
-
Sponsor GmbHGlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische StudienTerminatedMetastatic Breast Cancer | HER2 Positive | First or Second Line Therapy | Failure or Contraindication of Trastuzumab TherapyGermany
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)United States, United Kingdom, Korea, Republic of, Australia, Spain
-
University of Wisconsin, MadisonContext Therapeutics Inc.TerminatedMetastatic Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
AstraZenecaCompletedHER2-ve Metastatic Breast Cancer | Germline BRCA1/2 Mutations | Somatic BRCA1/2 MutationsItaly, Spain, Poland, Taiwan, Canada, France, Germany, Korea, Republic of, Hungary, Japan, Russian Federation, Turkey, United Kingdom, United States, Bulgaria
-
RemeGen Co., Ltd.RecruitingGastric Cancer | HER2 Overexpressing Gastric CarcinomaChina
-
Gary SchwartzWithdrawn
-
NSABP Foundation IncPfizerCompleted
-
Jazz PharmaceuticalsRecruitingBiliary Tract Cancer | HER2 Gene MutationUnited States, Puerto Rico
-
Jazz PharmaceuticalsBeiGene, Ltd.Active, not recruitingHER2-amplified Biliary Tract CancersUnited States, Spain, United Kingdom, Korea, Republic of, Canada, China, Italy, Chile, France
-
Daiichi SankyoAstraZenecaRecruiting
-
AstraZenecaRecruitingBreast Cancer | Breast Neoplasms | Breast Carcinoma | Genes | HER2Kuwait, Saudi Arabia, United Arab Emirates, Qatar
-
H. Lee Moffitt Cancer Center and Research InstituteVaccinex Inc.RecruitingHER2-positive Breast CancerUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Breast Cancer
-
University of MalayaNational University Hospital, Singapore; Merck Sharp & Dohme LLC; Cancer Research...RecruitingHER2-Negative Breast CancerSingapore, Malaysia
-
Daiichi Sankyo, Inc.Completed